MEDIOLANUM
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Dec 2023)
What this means for you
This application is over — abandoned 18 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88921116
- Mark type
- Stylized text
- Filed
- 18 May 2020
- Published for opposition
- 22 Sept 2020
- Abandoned
- 18 Dec 2023
- Attorney of record
- John Zaccaria
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in haematology, in oncology in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-bases disease, antivirals, anti-biotics, antifungals, vaccines
Owner
- MEDIOLANUM FARMACEUTICI S.P.A., MILANO, IT
- MEDIOLANUM FARMACEUTICI S.P.A., MILANO, IT
Prosecution history
- 18 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2023 — SOU EXTENSION 5 GRANTED
- 11 Apr 2023 — SOU EXTENSION 5 FILED
- 17 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 27 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2022 — SOU EXTENSION 4 GRANTED
- 23 Sept 2022 — SOU EXTENSION 4 FILED
- 23 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2022 — SOU EXTENSION 3 GRANTED
- 14 Mar 2022 — SOU EXTENSION 3 FILED
- 14 Mar 2022 — SOU TEAS EXTENSION RECEIVED